阿里健康(00241.HK)跌逾6% 阿里巴巴(09988.HK)擬發120億零息可換股債
阿里健康(00241.HK)低開低開4.9%後,跌幅擴大,現報4.2元,跌7.08%。成交量約1.2億股,涉資5.06億元。阿里巴巴(09988.HK)跌2.07%報104元。
阿里巴巴昨日收市後公布,擬發行本金總額為約120億港元,2032年到期的零息可換股債券,投資者可在債券發行後41日起,選擇換取阿里健康股份或現金。初始交換比率為每100萬元本金額的債券可交換約16.05萬股阿里健康股份,相當於每股阿里健康股份的初始交換價格為6.23元,較阿里健康昨日(3日)收市價4.52元溢價37.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.